IL-17D affects the chemokines and chemokine receptors of intestinal epithelial cells under hyperoxia.

[1]  Lin Wei,et al.  HCV Core Protein Induces Chemokine CCL2 and CXCL10 Expression Through NF-κB Signaling Pathway in Macrophages , 2021, Frontiers in Immunology.

[2]  D. Yoo,et al.  Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2 , 2021, Scientific Reports.

[3]  Xuying Liu,et al.  Nuclear factor erythroid 2-related factor 2 potentiates the generation of inflammatory cytokines by intestinal epithelial cells during hyperoxia by inducing the expression of Interleukin 17D. , 2021, Toxicology.

[4]  H. Chou,et al.  Neonatal hyperoxia induces gut dysbiosis and behavioral changes in adolescent mice. , 2021, Journal of the Chinese Medical Association : JCMA.

[5]  W. Lou,et al.  ROS Plays a Role in the Neonatal Rat Intestinal Barrier Damages Induced by Hyperoxia , 2020, BioMed research international.

[6]  Linlin Gao,et al.  Neonatal Hyperoxia Downregulates Claudin-4, Occludin, and ZO-1 Expression in Rat Kidney Accompanied by Impaired Proximal Tubular Development , 2020, Oxidative medicine and cellular longevity.

[7]  Kang Xu,et al.  Safflower yellow alleviates osteoarthritis and prevents inflammation by inhibiting PGE2 release and regulating NF-κB/SIRT1/AMPK signaling pathways. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[8]  Dongyan Zhang,et al.  Involvement of nuclear factor erythroid 2-related factor 2 in neonatal intestinal interleukin-17D expression in hyperoxia , 2020, International journal of molecular medicine.

[9]  I. Baranowska-Bosiacka,et al.  Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review , 2020, International journal of molecular sciences.

[10]  Xuying Liu,et al.  IL-17D: A Less Studied Cytokine of IL-17 Family , 2020, International Archives of Allergy and Immunology.

[11]  H. Chou,et al.  Cathelicidin attenuates hyperoxia-induced intestinal injury through inhibition of NF-κB activity in newborn rats. , 2020, Experimental and molecular pathology.

[12]  L. Baumbusch,et al.  Immune System Regulation Affected by a Murine Experimental Model of Bronchopulmonary Dysplasia: Genomic and Epigenetic Findings , 2019, Neonatology.

[13]  Shasha Liu,et al.  Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling , 2019, Journal of Immunotherapy for Cancer.

[14]  Chengfang Yao,et al.  Interleukin-17D Promotes Pathogenicity During Infection by Suppressing CD8 T Cell Activity , 2019, Front. Immunol..

[15]  Adrian Y. S. Lee,et al.  The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology. , 2019, Immunobiology.

[16]  I. Sandrock,et al.  A Subset of CCL25-Induced Gut-Homing T Cells Affects Intestinal Immunity to Infection and Cancer , 2019, Front. Immunol..

[17]  Yi Liu,et al.  Interleukin-17D Aggravates Sepsis by Inhibiting Macrophage Phagocytosis. , 2019, Critical care medicine.

[18]  A. Mildner,et al.  Developmental and Functional Heterogeneity of Monocytes. , 2018, Immunity.

[19]  Xiao-qing Chen,et al.  Bronchopulmonary dysplasia: Pathogenesis and treatment. , 2018, Experimental and therapeutic medicine.

[20]  C. Benedict,et al.  Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection , 2018, Scientific Reports.

[21]  D. Adams,et al.  Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise , 2018, Journal of Crohn's & colitis.

[22]  D. Farber,et al.  Human T Cell Development, Localization, and Function throughout Life. , 2018, Immunity.

[23]  Shinya Yamamoto,et al.  CCL28-Deficient Mice Have Reduced IgA Antibody–Secreting Cells and an Altered Microbiota in the Colon , 2018, The Journal of Immunology.

[24]  Vasantha H. S. Kumar,et al.  Adaptive immune responses are altered in adult mice following neonatal hyperoxia , 2018, Physiological reports.

[25]  Min Zhao,et al.  Reactive oxygen species induce injury of the intestinal epithelium during hyperoxia , 2017, International journal of molecular medicine.

[26]  H. Chou,et al.  Neonatal hyperoxia disrupts the intestinal barrier and impairs intestinal function in rats. , 2017, Experimental and molecular pathology.

[27]  N. Parameswaran,et al.  Epithelial Barrier Function in Gut-Bone Signaling. , 2017, Advances in experimental medicine and biology.

[28]  Dean P. Jones,et al.  Oxidative Stress. , 2017, Annual review of biochemistry.

[29]  Daniel R. Hoeber,et al.  Hyperoxia and the Immature Brain , 2017, Developmental Neuroscience.

[30]  H. Chou,et al.  Hyperoxia disrupts the intestinal barrier in newborn rats. , 2016, Experimental and molecular pathology.

[31]  D. Sheppard,et al.  IgA production requires B cell interaction with subepithelial dendritic cells in Peyer’s patches , 2016, Science.

[32]  C. Bain,et al.  Macrophages in intestinal homeostasis and inflammation , 2014, Immunological reviews.

[33]  H. Ikeda,et al.  Interleukin-17D mediates tumor rejection through recruitment of natural killer cells. , 2014, Cell reports.

[34]  E. Jabłońska,et al.  Expression of subtypes of interleukin-17 ligands and receptors in patients with B-cell chronic lymphocytic leukemia. , 2014, Clinical laboratory.

[35]  M. Teixeira,et al.  Targeting CCL5 in inflammation , 2013, Expert opinion on therapeutic targets.

[36]  N. Karin,et al.  The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications , 2013, Journal of leukocyte biology.

[37]  J. Neu,et al.  Arginyl-Glutamine Dipeptide or Docosahexaenoic Acid Attenuates Hyperoxia-induced Small Intestinal Injury in Neonatal Mice , 2012, Journal of pediatric gastroenterology and nutrition.

[38]  D. Baumgart,et al.  Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis , 2011, Inflammopharmacology.

[39]  A. Yoshida,et al.  Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model. , 2011, Investigative ophthalmology & visual science.

[40]  T. Hibi,et al.  Monocyte Chemoattractant Protein-1 Contributes to Gut Homeostasis and Intestinal Inflammation by Composition of IL-10–Producing Regulatory Macrophage Subset , 2010, The Journal of Immunology.

[41]  B. Liu,et al.  The antimicrobial activity of CCL28 is dependent on C‐terminal positively‐charged amino acids , 2009, European journal of immunology.

[42]  J. Li,et al.  Effect of hyperoxia on the intestinal IgA secretory component in neonatal rats and on intestinal epithelial cells in vitro. , 2010, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[43]  A. N. Larsen,et al.  Interleukin-17D in Atlantic salmon (Salmo salar): molecular characterization, 3D modelling and promoter analysis. , 2009, Fish & shellfish immunology.

[44]  P. Calder.  Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. , 2009, Biochimie.

[45]  M. O’Reilly,et al.  Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus. , 2008, American journal of respiratory and critical care medicine.

[46]  A. Glodek,et al.  Developmental stage-specific shift in responsiveness to chemokines during human B-cell development. , 2006, Experimental hematology.

[47]  P. Ducrotte,et al.  Glutamine Pretreatment Reduces IL-8 Production in Human Intestinal Epithelial Cells by Limiting IκBα Ubiquitination , 2006 .

[48]  Myriam Labalette,et al.  Accumulation of memory T cells from childhood to old age: Central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartment , 2006, Mechanisms of Ageing and Development.

[49]  U. Ritter,et al.  CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress. , 2003, Blood.

[50]  R. Hromas,et al.  Cutting Edge: IL-17D, a Novel Member of the IL-17 Family, Stimulates Cytokine Production and Inhibits Hemopoiesis1 , 2002, The Journal of Immunology.

[51]  B. Halliwell.  Reactive oxygen species in living systems: source, biochemistry, and role in human disease. , 1991, The American journal of medicine.